[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH0219117B2 - - Google Patents

Info

Publication number
JPH0219117B2
JPH0219117B2 JP57084459A JP8445982A JPH0219117B2 JP H0219117 B2 JPH0219117 B2 JP H0219117B2 JP 57084459 A JP57084459 A JP 57084459A JP 8445982 A JP8445982 A JP 8445982A JP H0219117 B2 JPH0219117 B2 JP H0219117B2
Authority
JP
Japan
Prior art keywords
group
compound
general formula
alkyl group
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57084459A
Other languages
Japanese (ja)
Other versions
JPS58201780A (en
Inventor
Shoichi Kakehi
Suketaka Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP57084459A priority Critical patent/JPS58201780A/en
Publication of JPS58201780A publication Critical patent/JPS58201780A/en
Publication of JPH0219117B2 publication Critical patent/JPH0219117B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は下記一般式(1)で示される新規な3−ビ
ニルインドリジン誘導体に関する。 (式中Rは水素原子、低級アルキル基又はフエ
ニル基を、R1は水素原子又は低級アルキル基を、
R2は水素原子又は低級アルキルチオ基を、R3
びR4はシアノ基、低級アルカノイル基又は低級
アルコキシカルボニル基を、R5は置換基として
低級アルコキシカルボニル基若しくはフエニル基
を有する低級アルキル基、低級アルカノイル基又
はベンゾイル基を意味する) 本発明において定義される低級アルキル基とし
てはメチル、エチル、プロピル、ブチル基等の炭
素数1〜4のアルキル基が、低級アルキルチオ基
としてはメチルチオ、エチルチオ、プロピルチ
オ、ブチルチオ基等の炭素数1〜4のアルキルチ
オ基が、低級アルコキシカルボニル基としてはメ
トキシカルボニル、エトキシカルボニル、プロポ
キシカルボニル、ブトキシカルボニル基等の炭素
数2〜5のアルコキシカルボニル基が、低級アル
カノイル基としてはアセチル、プロパノイル、ブ
タノイル、ペンタノイル基等の炭素数2〜5のア
ルカノイル基が挙げられる。 上記一般式(1)で示される本発明化合物は血小板
擬集抑制作用、抗炎症作用、抗アレルギー作用、
抗菌作用等を有し医薬として有用である。 以下に本発明化合物の製法について説明する。
本発明化合物は例えば一般式(2)で示されるピリジ
ニウム化合物に塩基を作用させ、次いで一般式(4)
で示されるオレフイン化合物を反応させると共に
一般式(5)で示されるハロゲン化物を反応させるこ
とにより製造される。 〈反応工程式〉 (各式中R及びR1〜R5は前記に同じであり、
R6は低級アルキル基を、R7は低級アルコキシ基
又は低級アルキルチオ基を、X及びYはハロゲン
原子を意味する) 上式において原料として使用されるビリジニウ
ム化合物2は公知の化合物であり、例えばジヤー
ナル・オブ・オーガニツク・ケミストリー(J.
Org.Chem)36、2451(1971)に記載の方法又は
これに準ずる方法により容易に合成することがで
きる。塩基としては例えば水酸化ナトリウム、水
酸化カリウム等の水酸化アルカリ金属、水酸化カ
ルシウム、水酸化マグネシウム等の水酸化アルカ
リ土類金属、炭酸水素ナトリウム、炭酸水素カリ
ウム等の炭酸水素アルカリ金属、炭酸ナトリウ
ム、炭酸カリウム等の炭酸アルカリ金属、炭酸カ
ルシウム、炭酸マグネシウム等の炭酸アルカリ土
類金属、ナトリウムメトキシド、ナトリウムエト
キシド、カリウムブトキシド等の金属アルコキシ
ド等の無機塩基、ピリジン、ピコリン、トリエチ
ルアミン、N−メチルピペリジン等の有機塩基が
挙げられる。塩基の使用量は適宜選択することが
できるが、一般にピリジニウム化合物2に対して
約1〜2倍当量程度使用するのが有利である。ビ
リジニウム化合物2と塩基との反応は通常溶媒中
で行われる。溶媒としては反応に不活性な溶媒で
あれば特に限定されないが、例えばメタノール、
エタノール、プロパノール等の低級アルコール
類、エーテル、テトラヒドロフラン、ジオキサン
等のエーテル等、ベンゼン、トルエン、キシレン
等の芳香族炭化水素類、クロロホルム、塩化メチ
レン、四塩化炭素等のハロゲン化炭化水素類、ジ
メチルスルホキシド、ジメチルホルムアミド等の
非プロトン性極性溶媒等の中から使用するビリジ
ニウム化合物2及び塩基の種類により適宜選択し
て使用される。反応温度は特に限定されないが、
通常−20〜150℃付近で行うと反応は有利に進行
する。 上記の反応により一般式(3)で示されるジヒドロ
インドリジン−2−オン化合物が生成する。これ
は通常の方法により反応系より単離可能である
が、本発明では特にこのジヒドロインドリジン−
2−オン化合物3を単離することなく引き続き反
応系内に一般式(4)で示されるオレフイン化合物及
び一般式(5)で示されるハロゲン化物を導入して反
応させることができる。オレフイン化合物4及び
ハロゲン化物5の使用量は適宜選択することがで
きるが、通常ビリジニウム化合物2に対してそれ
ぞれ約1〜5倍モル程度とするのが有利である。
反応温度は特に限定されないが一般に室温〜150
℃程度で行うのが有利である。本反応で生成する
3−ビニルインドリジン誘導体1は通常の分離手
段、例えば再結晶、カラムクロマトグラフイー等
により容易に単離可能である。 本発明の一般式(1)で示される3−ビニルインド
リジン誘導体において、R5が低級アルキル基で
ある化合物については、以下に示す如くハロゲン
化物5に代えて一般式(6)で示される化合物を反応
させることによつても製造することができる。 (式中R,R1〜R4,R6〜R7及びXは前記に同
じであり、R5′は低級アルキル基を意味する) 又、本発明の一般式(1)で示される3−ビニルイ
ンドリジン誘導体は以下に示す如くハロゲン化物
5に代えて一般式(7)で示される化合物を反応させ
ることによつても製造することができる。 (式中R,R1〜R4,R6〜R7及びXは前記に同
じであり、R5″は低級アルカノイル基又はベンゾ
イル基を意味する) 以下本発明の一般式(1)で示される3−ビニルイ
ンドリジン誘導体の代表例を挙げ、次いで各化合
物の製造例を実施例として挙げる。
The present invention relates to a novel 3-vinylindolizine derivative represented by the following general formula (1). (In the formula, R is a hydrogen atom, a lower alkyl group, or a phenyl group, R 1 is a hydrogen atom or a lower alkyl group,
R 2 is a hydrogen atom or a lower alkylthio group, R 3 and R 4 are a cyano group, lower alkanoyl group or lower alkoxycarbonyl group, R 5 is a lower alkyl group having a lower alkoxycarbonyl group or phenyl group as a substituent, lower The lower alkyl group defined in the present invention is an alkyl group having 1 to 4 carbon atoms such as methyl, ethyl, propyl, butyl group, and the lower alkylthio group is methylthio, ethylthio, propylthio. , an alkylthio group having 1 to 4 carbon atoms such as butylthio group, an alkoxycarbonyl group having 2 to 5 carbon atoms such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl group as a lower alkanoyl group, Examples include alkanoyl groups having 2 to 5 carbon atoms such as acetyl, propanoyl, butanoyl, and pentanoyl groups. The compound of the present invention represented by the above general formula (1) has platelet aggregation inhibiting action, anti-inflammatory action, anti-allergic action,
It has antibacterial effects and is useful as a medicine. The method for producing the compound of the present invention will be explained below.
The compound of the present invention can be prepared by, for example, reacting a base with a pyridinium compound represented by the general formula (2), and then forming the pyridinium compound represented by the general formula (4).
It is produced by reacting an olefin compound represented by formula (5) with a halide represented by general formula (5). <Reaction process formula> (In each formula, R and R 1 to R 5 are the same as above,
(R 6 is a lower alkyl group, R 7 is a lower alkoxy group or a lower alkylthio group, and X and Y are halogen atoms.) The viridinium compound 2 used as a raw material in the above formula is a known compound, such as a journal.・Of Organic Chemistry (J.
Org. Chem) 36 , 2451 (1971) or a similar method. Examples of bases include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide and magnesium hydroxide, alkali metal hydrogencarbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate, and sodium carbonate. , alkali metal carbonates such as potassium carbonate, alkaline earth metal carbonates such as calcium carbonate and magnesium carbonate, inorganic bases such as metal alkoxides such as sodium methoxide, sodium ethoxide and potassium butoxide, pyridine, picoline, triethylamine, N-methyl Examples include organic bases such as piperidine. Although the amount of the base to be used can be selected as appropriate, it is generally advantageous to use the base in an amount of about 1 to 2 times the amount of the pyridinium compound 2. The reaction between the viridinium compound 2 and the base is usually carried out in a solvent. The solvent is not particularly limited as long as it is inert to the reaction, but examples include methanol,
Lower alcohols such as ethanol and propanol, ethers such as ether, tetrahydrofuran, and dioxane, aromatic hydrocarbons such as benzene, toluene, and xylene, halogenated hydrocarbons such as chloroform, methylene chloride, and carbon tetrachloride, and dimethyl sulfoxide. , aprotic polar solvents such as dimethylformamide, etc., depending on the type of the viridinium compound 2 and the base used. The reaction temperature is not particularly limited, but
The reaction usually proceeds advantageously when carried out at around -20 to 150°C. The above reaction produces a dihydroindolizin-2-one compound represented by general formula (3). This can be isolated from the reaction system by a conventional method, but in the present invention, this dihydroindolizine-
Without isolating the 2-one compound 3, the olefin compound represented by the general formula (4) and the halide represented by the general formula (5) can be subsequently introduced into the reaction system and reacted. The amounts of the olefin compound 4 and the halide 5 to be used can be selected as appropriate, but it is usually advantageous to use about 1 to 5 times the molar amount of each of the viridinium compounds 2.
The reaction temperature is not particularly limited, but is generally room temperature to 150℃.
It is advantageous to carry out the reaction at a temperature of about 0.degree. The 3-vinylindolizine derivative 1 produced in this reaction can be easily isolated by conventional separation means such as recrystallization, column chromatography, etc. In the 3-vinylindolizine derivatives represented by the general formula (1) of the present invention, for compounds in which R 5 is a lower alkyl group, the compound represented by the general formula (6) is substituted for the halide 5 as shown below. It can also be produced by reacting. (In the formula, R, R 1 to R 4 , R 6 to R 7 and X are the same as above, and R 5 ' means a lower alkyl group) In addition, -Vinyl indolizine derivatives can also be produced by reacting a compound represented by general formula (7) in place of halide 5, as shown below. (In the formula, R, R 1 to R 4 , R 6 to R 7 and X are the same as above, and R 5 ″ means a lower alkanoyl group or a benzoyl group) Representative examples of 3-vinyl indolizine derivatives are listed below, and then production examples of each compound are listed as examples.

【表】【table】

【表】【table】

【表】【table】

【表】【table】

【表】 C H N C H

23 71.12 5.19 7.21 71.23 5.14
7.16
24 74.30 4.62 6.42 74.39 4.63
6.32
25 68.89 5.30 6.69 68.90 5.31
6.67
26 67.54 4.05 11.25 67.55 4.16 1
1.28
実施例 1 2−ベンジル−1−(エトキシカルボニルメチ
ル)ピリジニウムブロミド1.008g(3ミリモル)
を含むエタノール溶液60mlにナトリウムエトキシ
ドエタノール溶液6ml(6ミリモルのナトリウム
エトキシドを含む)を加え、60〜80℃に3分間反
応させた後、α−シアノ−β−エトキシ−アクリ
ル酸エチル0.507g(3ミリモル)を加える。こ
のまま1分間反応させた後、無水酢酸2mlを加え
5分間反応させる。反応混合物を減圧濃縮し残渣
をエーテル−クロロホルムを用いてアルミナカラ
ムで分離した後、エタノールから再結晶して2−
アセトキシ−3−(2−シアノ−2−エトキシカ
ルボニルビニル)−1−フエニルインドリジン
(化合物No.19)を得た。 実施例1と同様の方法により、他の化合物を合
成した。
[Table] C H N C H
N
23 71.12 5.19 7.21 71.23 5.14
7.16
24 74.30 4.62 6.42 74.39 4.63
6.32
25 68.89 5.30 6.69 68.90 5.31
6.67
26 67.54 4.05 11.25 67.55 4.16 1
1.28
Example 1 2-benzyl-1-(ethoxycarbonylmethyl)pyridinium bromide 1.008 g (3 mmol)
60 ml of sodium ethoxide ethanol solution (containing 6 mmol of sodium ethoxide) was added to 60 ml of ethanol solution containing sodium ethoxide, and after reacting at 60 to 80°C for 3 minutes, 0.507 g of ethyl α-cyano-β-ethoxy-acrylate (3 mmol) is added. After reacting for 1 minute, add 2 ml of acetic anhydride and react for 5 minutes. The reaction mixture was concentrated under reduced pressure, the residue was separated on an alumina column using ether-chloroform, and then recrystallized from ethanol to give 2-
Acetoxy-3-(2-cyano-2-ethoxycarbonylvinyl)-1-phenylindolizine (Compound No. 19) was obtained. Other compounds were synthesized in the same manner as in Example 1.

Claims (1)

【特許請求の範囲】 1 一般式 (式中Rは水素原子、低級アルキル基又はフエ
ニル基を、R1は水素原子又は低級アルキル基を、
R2は水素原子又は低級アルキルチオ基を、R3
びR4はシアノ基、低級アルカノイル基又は低級
アルコキシカルボニル基を、R5は置換基として
低級アルコキシカルボニル基若しくはフエニル基
を有する低級アルキル基、低級アルカノイル基又
はベンゾイル基を意味する)で示される3−ビニ
ルインドリジン誘導体。
[Claims] 1. General formula (In the formula, R is a hydrogen atom, a lower alkyl group, or a phenyl group, R 1 is a hydrogen atom or a lower alkyl group,
R 2 is a hydrogen atom or a lower alkylthio group, R 3 and R 4 are a cyano group, lower alkanoyl group or lower alkoxycarbonyl group, R 5 is a lower alkyl group having a lower alkoxycarbonyl group or phenyl group as a substituent, lower A 3-vinylindolizine derivative represented by an alkanoyl group or a benzoyl group.
JP57084459A 1982-05-18 1982-05-18 3-vinylindolizine derivative and its preparation Granted JPS58201780A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57084459A JPS58201780A (en) 1982-05-18 1982-05-18 3-vinylindolizine derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57084459A JPS58201780A (en) 1982-05-18 1982-05-18 3-vinylindolizine derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS58201780A JPS58201780A (en) 1983-11-24
JPH0219117B2 true JPH0219117B2 (en) 1990-04-27

Family

ID=13831205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57084459A Granted JPS58201780A (en) 1982-05-18 1982-05-18 3-vinylindolizine derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS58201780A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112833A (en) * 1988-12-26 1992-05-12 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives, synthetic intermediates thereof and antiallergic agents containing 1-azaindolizine derivatives
JP2008101064A (en) * 2006-10-17 2008-05-01 Tdk Corp Dye, electrode and photoelectric conversion element

Also Published As

Publication number Publication date
JPS58201780A (en) 1983-11-24

Similar Documents

Publication Publication Date Title
JP2556722B2 (en) Novel sulfonamide compound
CN108794412B (en) Preparation method of 4, 5-diaryl-2H-1, 2, 3-triazole compound
JP2731853B2 (en) Method for producing tri-lower alkanoyloxyboron
JPH0219117B2 (en)
JPS58164577A (en) 4-benzyl-1-(2h)isoquinolone derivative and preparation thereof
IL28645A (en) Tropine derivatives
US4115642A (en) Method for preparing auranofin
JP2002105058A (en) Method for manufacturing 1,3-dialkylimidazolium iodide salt
CA1137482A (en) Process for the production of 5-aminoisoxazoles
JPH11130752A (en) Production of heteroaryl carboxylic amide and ester
EP1471058B1 (en) Process for producing 1,2,3-triazole compound
JPH0217549B2 (en)
JP2603108B2 (en) Anilinopyrimidine derivative
KR810000859B1 (en) Method for preparing derivatives of 7-amino- 3-desacetoxy cephalosporanic acid
US4334088A (en) 2-Alkynyl-5-indanyloxyacetic acids
JPH0217550B2 (en)
JPH0220638B2 (en)
US4260544A (en) Halogenomethylene-indoxyls
JPH06228103A (en) New octahydroacridine derivative and its production
KR830000634B1 (en) How to prepare N-trityl imidazole compound
JP3706154B2 (en) Novel halomethylene compounds or salts thereof
JPH0641066A (en) Production of pyrrole derivative
US4569999A (en) 2-Substituted-3-sulfonamide-pyridine derivatives
US4291168A (en) Silylated indanyloxyacetates
KR790001654B1 (en) Process for the preparation of s-triazolo(3,4-b)benzothiazoles